Jump to navigation
Main menu
Home
About
Leadership Team
Board of Directors
Corporate Governance
Corporate Development
Products
U.S. Marketed Products
Globally Marketed Products
Pipeline
Cardiovascular Care
Infectious Disease Care
Surgery & Perioperative Care
Portfolio
Investors
Press Releases
Events/Presentations
Financial Information
SEC Filings
Annual and Quarterly Reports
Stock Information
Trading History
Analyst Coverage
Investor FAQ
Information Request
Careers
Our Culture
Career Opportunities
Contact
Global Medical Information
Educational Grant Requests
Research Proposals & Grant Requests
Patient Assistance Programs
Search
The Medicines Company
Home
About
Leadership Team
Board of Directors
Corporate Governance
Corporate Development
Products
U.S. Marketed Products
Globally Marketed Products
Pipeline
Cardiovascular Care
Infectious Disease Care
Surgery & Perioperative Care
Portfolio
Investors
Press Releases
Events/Presentations
Financial Information
SEC Filings
Annual and Quarterly Reports
Stock Information
Trading History
Analyst Coverage
Investor FAQ
Information Request
Careers
Our Culture
Career Opportunities
Contact
Global Medical Information
Educational Grant Requests
Research Proposals & Grant Requests
Patient Assistance Programs
Search
Search form
Search
Banner Image
You are here
Home
›
Investors
Press Releases
Search
Year
2017
2016
2015
2014
2013
2012
2011
2010
January
25 Jan 2017
The Medicines Company to Present Results from ORION-1 Phase 2 Study of Inclisiran at the American College of Cardiology’s 66th Annual Scientific Session
P
8 Jan 2017
The Medicines Company Announces Positive Top-Line Results from Day 180 Interim Analysis in Ongoing ORION-1 Phase 2 Study of Inclisiran (formerly, PCSK9si)
P
4 Jan 2017
The Medicines Company to Present at J. P. Morgan Healthcare Conference
P
